Rite-Aid Surges after Better-than-Expected Q1 Results
Market News

Rite-Aid Surges after Better-than-Expected Q1 Results

Shares of drugstore chain, Rite-Aid Corp. (NYSE: RAD) went up in pre-market trading at the time of writing on Thursday after the company’s losses narrowed in Q1 to $0.73 per share versus an adjusted loss of $0.86 per share in the same period last year while analysts were expecting the company to report a loss of $1.50 per share.

The company’s revenues, however, declined to $5.65 billion in Q1 as compared to $6.01 billion in the same period last year but exceeding consensus estimates of $5.32 billion. Rite-Aid stated in its press release that this fall in revenues was driven by “largely due to the reduction in the Company’s Prescription Drug Plan (PDP) membership and the loss of commercial clients at Elixir. “

Looking forward, the company expects total revenues to be between $22.6 billion and $23 billion in FY24, while adjusted net loss is likely to be in the range of $4.29 and $4.78 per share. RAD reduced its FY24 adjusted EBITDA guidance by $10 million to be in the range of $330 million to $360 million.

RAD stock has not fared well this year, down by more than 50%.

Tired of arriving late to the Big Returns Party?​
Most investors don’t have major gainers like TSLA or NVDA on their radar from the start.
The profusion of opinions on social media and financial blogs makes it impossible to distinguish between real growth potential and pure hype.
​​For the past decade, we have developed and perfected technology designed to help private investors, just like you, find the best opportunities, with the greatest upside potential, in any financial climate.​
Learn More
Rite-Aid Surges after Better-than-Expected Q1 Results
News On DemandStay up-to-date on market-moving news with a feed made just for youGet the App

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100
RUT
Russell 2000
TNX
10-Yr-Bond
Bitcoin

Popular Articles